ArticleJAMA network open2021
Therapeutic Neuromodulation for Bipolar Disorder-The Case for Biomarker-Driven Treatment Development.
Joan A CamprodonPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it